Nationwide studies show remnant cholesterol inflammatory index predicts diabetes risk in specific populations, suggesting broader health implications.
RCII shows a consistent association with incident diabetes across both Chinese and UK cohorts, whereas its relationships with other chronic diseases were observed only in the UK cohort. These findings suggest that RCII may serve as a robust marker for diabetes risk and a broader indicator of multisystem vulnerability in certain populations, warranting cautious interpretation and further validation.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: